The Immunotherapy has over 2.51K+ startups that comprising companies developing immunotherapy to treat diseases in humans. It also includes antibodies, vaccines, cytokines, small molecules based immunotherapy for the treatment of various diseases.
Immunotherapy sector is one of the most active sectors for investors with an overall funding of USD 133B in 1.89K+ companies. It is also interesting to note that more than fourth of the funding has been raised in the last 3 years (2023-2025).
HHS, Europa, Orbimed, RA Capital Management, NIH are amongst the most active investors in this sector by number of investments.
Disease-Targeting, immunomodulatory, diversified, t-cell, tumor are some of the top business models attracting major funding.
We, at Tracxn, keep a track of the latest happenings in the world of startups and their associated ecosystems – including venture capital funds, private equity funds and investment banks amongst others.
In this edition, we have the Immunotherapy startups 2026 – a curated list of the most promising startups leading the Immunotherapy industry, from across the globe.